Target intelligence / Profile preview

Insulin receptor substrate (IRS)

Target
IRS
Molecular classification
Other, Adaptor protein, Cytoplasmic docking protein
01

Overview

Insulin receptor substrate (IRS) proteins, primarily IRS-1 and IRS-2, are critical cytoplasmic adaptor molecules that mediate signaling downstream of the insulin receptor (IR) and insulin-like growth factor 1 receptor (IGF-1R). Upon ligand binding, the activated receptors phosphorylate IRS proteins on tyrosine residues, allowing them to recruit and activate key downstream effectors such as phosphoinositide 3-kinase (PI3K)/Akt and mitogen-activated protein kinase (MAPK) pathways. These cascades regulate essential cellular processes, including glucose homeostasis, lipid metabolism, cell growth, survival, and proliferation. Dysregulation of IRS signaling is heavily implicated in metabolic diseases like type 2 diabetes and obesity, where impaired IRS activation leads to insulin resistance. Additionally, constitutive activation or overexpression of IRS proteins is common in various cancers, promoting tumor growth, metastasis, and resistance to targeted therapies. Consequently, IRS has emerged as an attractive therapeutic target, with small-molecule inhibitors like NT157 and NT219 designed to induce IRS degradation, thereby blocking oncogenic signaling and overcoming drug resistance.

Other names
Insulin receptor substrate familyIRS familyIRS proteinsInsulin receptor substrate proteins
02

Mechanism of action

Allosteric inhibition, serine phosphorylation, and proteasomal degradation of IRS-1/2, or RNA interference-mediated knockdown of IRS-1

03

Biological functions

Signal transductionCell proliferationCell survivalApoptosisGlucose metabolism
04

Disease associations

CancerDiabetesObesityNeurodegenerative disease
05

Safety considerations

Insulin resistanceHyperglycemiaImpaired glucose toleranceInfusion-related reactionsHypertensionHeadacheNausea
06

Interacting drugs

2 more in the full profile.

07

Biomarkers

IRS-1 expressionIRS-2 expressionIRS-1 serine phosphorylationIGF-1R expressionpSTAT3 expression

Beyond the preview

Go deeper on Insulin receptor substrate (IRS).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Insulin receptor substrate (IRS).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call